Company intelligence / Profile preview

International Institute for the Brain

New York City, New York, United States

Ownership: Private
Employees: ~167
Development stage: Other

Overview

iBRAIN Institute conducts translational research and implements innovative education and therapeutic services for individuals with severe brain injuries and brain-based disorders, including pioneering use of robotics (e.g., exoskeletons) and personalized multi-modality approaches to maximize rehabilitation outcomes. They are not engaged in drug development or therapeutic clinical trials but focus on measurable educational, functional, and mobility improvements in pediatric cohorts.

Therapeutic areas: Neurology
Modalities: DeviceRehabilitation therapyAssistive technology
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on International Institute for the Brain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Institute for the Brain.

Explore the full profile